Thursday 26th November 2020

(3 years, 5 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

Unfortunately, we will not be removing that requirement from tier 2. It is incredibly important that we keep the cases under control. The local team in Warrington has worked very hard along with the Liverpool city region to get the case rate down. They went into national lockdown in tier 3 and have come out in tier 2, and the people of Warrington should be commended for that, but the measures of tier 2 are necessary to keep the virus under control because, unfortunately, the virus thrives when people get together. The hon. Member mentioned the point about events in larger scale. They will only be held where there is very stringent social distancing, so there will not be congregations, as she said, of thousands of people—I would like to reassure her of that—because these events will only take place when the capacity in normal times of any venue is much, much bigger than the number of people who are there.

Suzanne Webb Portrait Suzanne Webb (Stourbridge) (Con)
- Hansard - -

First, I want to thank residents in my constituency for their hard work and sacrifice; their borough has been hard hit by the virus. With my constituency being in one of the worst affected areas, will my right hon. Friend consider rolling out the vaccine as a priority when it is ready to the country’s worst affected areas, which have been not only blighted by this virus, but hard hit economically? These are the areas that will be in much need of assistance to get back on their feet following prolonged lockdown of the local economy. The vaccine would provide much needed respite in these worst affected areas.

Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

We have taken the decision to roll out the vaccine UK-wide at the same pace. I want to get it as soon as possible to the west midlands and to everywhere else, but it is fair to the areas that have had a low, or relatively low, incidence of the disease to make sure that they also have access to the vaccine. Also, the incidence in different parts of the country changes, and the vaccine roll-out programme is very complicated. It does not speed up the delivery of the vaccine in one area to have slowed it down in another. That is why we have taken a UK-wide approach.